Molecular imaging probes for 31P contrast

Molecular imaging probes for 31P contrast

<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...

Full description

Bibliographic Details
Main Author:	Tear, L
Other Authors:	Faulkner, S
Format:	Thesis
Language:	English
Published:	2018
Subjects:	Contrast media (Diagnostic imaging) Nuclear magnetic resonance spectroscopy Gadolinium

Similar Items

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
by: T Mortezazadeh, et al.
Published: (2020-02-01)

Magnetic Resonance Imaging Contrast Agents: A Review of Literature
by: Zahra Sahraei, et al.
Published: (2015-10-01)

Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
by: Marco Moscatelli, et al.
Published: (2023-10-01)

Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
by: Caterina Beatrice Monti, et al.
Published: (2020-04-01)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
by: Simona Bussi, et al.
Published: (2020-02-01)

MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders—Is Gadolinium Contrast Administration Actually Needed?
by: Marta Michali-Stolarska, et al.
Published: (2021-10-01)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
by: Johannes M. Froehlich, et al.
Published: (2023-04-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
by: Silvia Maria Lattanzio
Published: (2021-05-01)

Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
by: V. O. Panov, et al.
Published: (2016-09-01)

Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review
by: Susana Coimbra, et al.
Published: (2024-04-01)

Gadolinium Deposition in the Brain and Body
by: Aart J. van der Molen
Published: (2019-11-01)

Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report
by: Nguyen Chilan, et al.
Published: (2020-08-01)

Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction
by: Benjamin P. Bonner, et al.
Published: (2023-04-01)

Gadolinium retention after contrast-enhanced magnetic resonance imaging: A narrative review
by: Afnan Fahd Al-Muhanna
Published: (2022-01-01)

Novel MR imaging contrast agents for cancer detection
by: Daryoush Shahbazi-Gahrouei
Published: (2009-05-01)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
by: Jan M. Brendel, et al.
Published: (2023-05-01)

Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection
by: Valentina Visani, et al.
Published: (2024-02-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
by: Atiya Fatima, et al.
Published: (2021-09-01)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
by: Rong Lu, et al.
Published: (2020-12-01)

A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media
by: Yi Lee, et al.
Published: (2019-11-01)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
by: Xiaodong Li, et al.
Published: (2020-11-01)

Gadolinium-Cyclic 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Click-Sulfonyl Fluoride for Probing Serine Protease Activity in Magnetic Resonance Imaging
by: Phuong Tu Huynh, et al.
Published: (2023-04-01)

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study
by: Jarl Åsbjørn Jakobsen, et al.
Published: (2021-04-01)

Nephrogenic systemic fibrosis: Current concepts
by: Prasanta Basak, et al.
Published: (2011-01-01)

The Use of Gadolinium in Musculoskeletal MRI—Time to Rethink?
by: Arwa Elawad, et al.
Published: (2021-07-01)

MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
by: E. S. Kamyshova, et al.
Published: (2019-03-01)

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
by: Bang J. Guo, et al.
Published: (2018-09-01)

Dynamic nuclear polarisation as a probe of metabolism in pathophysiology
by: Miller, J
Published: (2015)

Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging
by: Katie L. Peterson, et al.
Published: (2018-05-01)

Molecular Dynamics Simulations of the Internal Mobility of Gd3+-Based MRI Contrast Agents: Consequences for Water Proton Relaxivity
by: Alain Borel, et al.
Published: (2004-04-01)

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol
by: Moreno Zanardo, et al.
Published: (2023-05-01)

Unusual Magnetic Resonance Imaging Findings Contrast-induced Encephalopathy following Cerebral Angiography
by: Won Ho Cho, et al.
Published: (2021-12-01)

Effects of chemical forms of gadolinium on the spleen in mice after single intravenous administration
by: Ryosuke Nakamura, et al.
Published: (2022-03-01)

Absolute quantification of human in vivo hepatic 31P magnetic resonance spectroscopy at 7 tesla
by: Purvis, L
Published: (2018)

31P nuclear magnetic resonance study on binary germanium phosphate glasses /
by: 218458 Abdel Wahab Mohamed Ali Hussein, et al.
Published: (2002)

Gadolinium-Coated Mesoporous Silica Nanoparticle for Magnetic Resonance Imaging
by: Zhongtao Li, et al.
Published: (2022-02-01)

Heavily Gd-Doped Non-Toxic Cerium Oxide Nanoparticles for MRI Labelling of Stem Cells
by: Anton L. Popov, et al.
Published: (2023-01-01)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
by: Neil Zaki, et al.
Published: (2020-12-01)

Contrast Medium Hypersensitivity: A Large Italian Study with Long-Term Follow-Up
by: Eleonora Nucera, et al.
Published: (2022-03-01)

Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: The Physio-Pathological Conditions for the Perfect Murder
by: Francesca Martino, et al.
Published: (2021-01-01)